Biostage Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Biostage are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Biostage has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Biostage is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.1 M |
Biostage |
Biostage Relative Risk vs. Return Landscape
If you would invest (100.00) in Biostage on December 17, 2024 and sell it today you would earn a total of 100.00 from holding Biostage or generate -100.0% return on investment over 90 days. Biostage is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Biostage, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biostage Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biostage's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Biostage, and traders can use it to determine the average amount a Biostage's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BSTG |
Based on monthly moving average Biostage is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biostage by adding Biostage to a well-diversified portfolio.
Biostage Fundamentals Growth
Biostage OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Biostage, and Biostage fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biostage OTC Stock performance.
| Return On Equity | -4.92 | |||
| Return On Asset | -2.11 | |||
| Current Valuation | 78.64 M | |||
| Shares Outstanding | 11.64 M | |||
| Price To Earning | (0.16) X | |||
| Price To Book | 28.47 X | |||
| EBITDA | (8.36 M) | |||
| Cash And Equivalents | 4.64 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 115 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | (0.16) X | |||
| Cash Flow From Operations | (2.63 M) | |||
| Earnings Per Share | (0.89) X | |||
| Total Asset | 1.87 M | |||
| Retained Earnings | (65.78 M) | |||
| Current Asset | 7.88 M | |||
| Current Liabilities | 654 K | |||
Things to note about Biostage performance evaluation
Checking the ongoing alerts about Biostage for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Biostage help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biostage is not yet fully synchronised with the market data | |
| Biostage has some characteristics of a very speculative penny stock | |
| Biostage has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biostage currently holds about 4.64 M in cash with (2.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. | |
| Roughly 51.0% of the company shares are held by company insiders |
- Analyzing Biostage's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biostage's stock is overvalued or undervalued compared to its peers.
- Examining Biostage's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biostage's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biostage's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Biostage's otc stock. These opinions can provide insight into Biostage's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |